SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ISIS?

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
From: olduser5/5/1996 11:23:00 PM
   of 30
 
I own both companies at substantially lower prices and like them very much as long term holds in a diversified biotech portfolio. Isis focuses on anti-sense technology which I must admit I don't understand very well. However its business and research principals are all highly thought of. Vical is a gene therapy company that is in the midst of publishing major results in several medical and research journals. I bought it at around 10/share and it's jumped up substantially from there. However, it's a great long term bet in my mind. I am a very patient long term holder of both stocks. I will be buying more on any severe correction in the price of either as long as the price drop isn't caused by business or research problems within either company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext